Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC.

JAMA. 2014 May 14;311(18):1889-900. doi: 10.1001/jama.2014.3628. Review.

PMID:
24825644
2.

Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings [Internet].

Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May.

3.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001867. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD001867.

PMID:
15674887
4.

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.

Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C.

Addiction. 2015 Jun;110(6):920-30. doi: 10.1111/add.12875. Epub 2015 Mar 17. Review.

PMID:
25664494
5.

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.

PLoS Med. 2015 Dec 22;12(12):e1001924. doi: 10.1371/journal.pmed.1001924. eCollection 2015 Dec. Review.

6.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2002;(2):CD001867. Review. Update in: Cochrane Database Syst Rev. 2005;(1):CD001867.

PMID:
12076425
7.

Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW.

Addiction. 2013 Feb;108(2):275-93. doi: 10.1111/j.1360-0443.2012.04054.x. Epub 2012 Oct 17. Review.

8.

Acamprosate for alcohol dependence.

Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD004332. doi: 10.1002/14651858.CD004332.pub2. Review.

PMID:
20824837
9.

Opioid antagonists for alcohol dependence.

Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD001867. doi: 10.1002/14651858.CD001867.pub2. Review.

PMID:
21154349
10.

Topiramate for the prophylaxis of episodic migraine in adults.

Linde M, Mulleners WM, Chronicle EP, McCrory DC.

Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010610. doi: 10.1002/14651858.CD010610. Review.

PMID:
23797676
11.

Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.

Falk D, Wang XQ, Liu L, Fertig J, Mattson M, Ryan M, Johnson B, Stout R, Litten RZ.

Alcohol Clin Exp Res. 2010 Dec;34(12):2022-34. doi: 10.1111/j.1530-0277.2010.01290.x.

PMID:
20659066
12.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

13.

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

Bouza C, Angeles M, Muñoz A, Amate JM.

Addiction. 2004 Jul;99(7):811-28. Review. Erratum in: Addiction. 2005 Apr;100(4):573. Magro, Angeles [corrected to Angeles, Magro].

PMID:
15200577
14.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2000;(3):CD001867. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD001867.

PMID:
10908513
15.

Pharmacological treatment of alcohol dependence: a review of the evidence.

Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT.

JAMA. 1999 Apr 14;281(14):1318-25.

PMID:
10208148
16.

Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.

Klimas J, Tobin H, Field CA, O'Gorman CS, Glynn LG, Keenan E, Saunders J, Bury G, Dunne C, Cullen W.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD009269. doi: 10.1002/14651858.CD009269.pub3. Review.

PMID:
25470303
17.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
18.
19.

Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Jonas DE, Garbutt JC, Amick HR, Brown JM, Brownley KA, Council CL, Viera AJ, Wilkins TM, Schwartz CJ, Richmond EM, Yeatts J, Evans TS, Wood SD, Harris RP.

Ann Intern Med. 2012 Nov 6;157(9):645-54. Review.

PMID:
23007881
20.

Supplemental Content

Support Center